Sequana Medical NV Cash Flow Conversion Efficiency

Latest as of June 2025: 0.254x

Sequana Medical NV cash flow conversion efficiency. Based on the latest financial reports, Sequana Medical NV (SEQUA) has a cash flow conversion efficiency ratio of 0.254x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-9.93 Million ≈ $-11.61 Million USD) by net assets (€-39.17 Million ≈ $-45.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Sequana Medical NV (2015–2024)

Cash flow conversion efficiency of Sequana Medical NV from 2015 to 2024. This chart illustrates how Sequana Medical NV's cash flow conversion efficiency has evolved over time, based on yearly financial data. View SEQUA stock price and chart for real-time trading data and today's change.

Sequana Medical NV Cash Flow Conversion Ratio Explained

Sequana Medical NV cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Sequana Medical NV Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sequana Medical NV ranked by their cash flow conversion efficiency. Also see Sequana Medical NV stock valuation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
NexMetals Mining Corp. Common Shares NASDAQ:NEXM	-0.150x
Ene Technology Inc TW:6243	0.037x
Clene Inc. NASDAQ:CLNN	0.104x
Manomay Tex India Limited NSE:MANOMAY	-0.100x
Helium Evolution Inc V:HEVI	-0.028x
Inter Industries TA:ININ	0.229x
Etherstack Plc AU:ESK	0.073x
One and One Green Technologies. Inc Class A Ordinary Shares NASDAQ:YDDL	N/A

Annual Cash Flow Conversion Efficiency for Sequana Medical NV (2015–2024)

The table below shows the annual cash flow conversion efficiency of Sequana Medical NV from 2015 to 2024. Review SEQUA free cash flow debt coverage to assess the company's free cash flow relative to its total liabilities.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€-44.38 Million ≈ $-51.88 Million	€-20.26 Million ≈ $-23.68 Million	0.456x	-69.43%
2023-12-31	€-19.47 Million ≈ $-22.76 Million	€-29.06 Million ≈ $-33.98 Million	1.493x	-88.30%
2022-12-31	€-2.15 Million ≈ $-2.52 Million	€-27.48 Million ≈ $-32.13 Million	12.763x	-57.47%
2021-12-31	€-786.92K ≈ $-919.99K	€-23.62 Million ≈ $-27.61 Million	30.012x	+119.90%
2020-12-31	€112.76K ≈ $131.83K	€-17.01 Million ≈ $-19.88 Million	-150.806x	-655.51%
2019-12-31	€925.93K ≈ $1.08 Million	€-18.48 Million ≈ $-21.61 Million	-19.961x	-3891.86%
2018-12-31	€-18.76 Million ≈ $-21.93 Million	€-9.88 Million ≈ $-11.55 Million	0.526x	-72.08%
2017-12-31	€-4.61 Million ≈ $-5.39 Million	€-8.69 Million ≈ $-10.16 Million	1.885x	-1.40%
2016-12-31	€-6.67 Million ≈ $-7.80 Million	€-12.75 Million ≈ $-14.90 Million	1.912x	-95.17%
2015-12-31	€-284.66K ≈ $-332.79K	€-11.26 Million ≈ $-13.16 Million	39.554x	--

About Sequana Medical NV

BR:SEQUA Belgium Medical Devices

Market Cap

$55.84 Million

€47.76 Million EUR

Market Cap Rank

#21880 Global

#91 in Belgium

Share Price

€0.61

Change (1 day)

+0.00%

52-Week Range

€0.47 - €0.76

All Time High

€11.80